[Rubella seroprevalence in 234 military young women aged between 19 and 31 years].
OBJECTIVE
The main objectives of this study were to estimate, among young French women joining the french army, 1) their protective immunity against rubella, 2) the origin of this immunity (immunization or infection), 3) the rubella vaccine coverage and 4) the knowledge of these subjects on the disease and its methods of prevention.


METHODS
The study was conducted between December 1(st) 2006 and April 30(th) 2007 among 234 military women born 1976 to 1987. The results of rubella serology were obtained either in the medical files or after prescription of a serology. The dates of vaccination were collected on the military medical files and on the personal health records. A questionnaire was used to estimate the knowledge of these women on rubella.


RESULTS
234 women were included in our study. Results of serology were available for 224 of them. The serologic susceptibility to rubella virus was 6.7%. The mean age at the time of the serological investigation was 21.9 years. The vaccinal history was able to be collected for 45% of the immune women and 7 of the 15 non-immune women. Among the immune women, 74% had an antecedent of vaccination against rubella. The rate of rubella vaccine coverage was estimated at 70.5%. The proportion of the non-vaccinated immune women decreased during time, for the benefit of the vaccinated immune women. The knowledge on rubella disease did not differ according to the maternal status of the women. Near a quarter of them ignored the disastrous consequences for he foetus.


CONCLUSIONS
This study shows a high seroprevalence of about 93% while the rubella vaccine coverage is estimated at 70.5%, letting suppose the persistence of the wild virus. The prevention campaigns and the efforts begun to vaccine all the non-immune women of childbearing age must be pursued.
Senèze
Catherine
C
Service médical de la base aérienne 217, F-91224 Brétigny-sur-Orge, France. catherine.seneze@wanadoo.fr
Haus-Cheymol
Rachel
R
Hanslik
Thomas
T
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D005602:France; D006801:Humans; D008889:Military Personnel; D012409:Rubella / Q000097:blood* / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine; D016036:Seroepidemiologic Studies; D055815:Young Adult
D000914:Antibodies, Viral; D012411:Rubella Vaccine; C040901:rubella antibodies